Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Acronyms VITAL-DKD
- 24 Oct 2020 Results of secondary analysis examining the effects of vitamin D(3) and/or n 3 fatty acid supplementation vs placebo on 5 year changes in serum inflammatory and cardiac biomarkers in adults with type 2 diabetes published in the Diabetologia
- 10 Jun 2020 Status changed from active, no longer recruiting to completed.
- 08 Nov 2019 Results published in the JAMA: the Journal of the American Medical Association